Urine-Based Biomarker Test Uromonitor® in the Detection and Disease Monitoring of Non-Muscle-Invasive Bladder Cancer—A Systematic Review and Meta-Analysis of Diagnostic Test PerformanceAnton Kravchuk, Matthias May, Ingmar Wolff et al.|Cancers|2024Cited by 18
Evaluating the Use of Prostate-Specific Antigen as an Instrument for Early Detection of Prostate Cancer beyond Urologists: Results of a Representative Cross-Sectional Questionnaire Study of General Practitioners and Internal SpecialistsChristian Gilfrich, Ingmar Wolff, Thorsten Ecke et al.|Urologia Internationalis|2014Cited by 4
Early detection efforts for colorectal and prostate cancer from the patient’s perspective over the course of 12 years: results of the KABOT survey studyKay-Patrick Braun, Markus Herrmann, Julia Maurer et al.|Primary Health Care Research & Development|2024Cited by 1
Changes in PSA-Based Early Detection of Prostate Cancer Over a 12-Year Period: Findings from the German KABOT StudyKay-Patrick Braun, Ingmar Wolff, Torsten Vogel et al.|Preprints.org|2026Cited by 0
Changes in PSA-Based Early Detection of Prostate Cancer over a 12-Year Period: Findings from the German KABOT StudyKay-Patrick Braun, Ingmar Wolff, Torsten Vogel et al.|Healthcare|2026Cited by 0